Adiponectin performed better than chance (i.e., the AUC was significantly greater than 0.5) in classifying correctly subjects with MetS, both in the model that adjusted only for sex and age, as well as in the model that further adjusted for insulin, BMI or waist circumference (Table 6). This evidence concerns the gene INS and metabolic syndrome.